Overview
Portfolio
More
Entourageeffect
Invests in cannabis sector leveraging the “entourage effect” to create value across the industry.
Portfolio
32+
Employees
10+
Founded
2014
AUM
≈ $250.0M
Investment focus
Stages
No stages listed
Industries
No industries listedFund details
Funds
Entourage Effect Capital Fund III
Vintage 2021 • $150.0M
Entourage Effect Capital Fund II
Vintage 2019
Sources
Entourageeffect
Invests in cannabis sector leveraging the “entourage effect” to create value across the industry.
Portfolio
32+
Employees
10+
Founded
2014
AUM
≈ $250.0M
Funds
Entourage Effect Capital Fund III · Vintage 2021 • $150.0M
Entourage Effect Capital Fund II · Vintage 2019
Showing 9 of 9 matched portfolio companies
AGR develops spectral sensing engines integrated with tractor-mounted cameras and edge-AI for early agricultural diagnostics. This technology identifies fungal, pest, viral, nutrient, and water issues in crops up to one week sooner than traditional methods. The system provides high-accuracy data for real-time spray reduction or prescription mapping for sprayer OEMs and custom applicators.
BDSA provides cannabis market intelligence through its GreenEdge® platform, delivering real‑time, SKU‑level sales, pricing, and basket analytics across U.S. and Canadian dispensaries. The service offers consumer segmentation, demographic insights, and predictive market forecasts for over 40 countries, plus Retail Site IQ tools that identify optimal new‑store locations and acquisition targets. Brands, retailers, and investors use these data‑driven dashboards, reports, and APIs to optimize pricing, assortment, promotions, and expansion strategies.
Funding: $7.0M
Rough estimate of the amount of funding raised
Funding: $7.0M
Rough estimate of the amount of funding raised
Cann produces low-dose tetrahydrocannabinol (THC) beverages that provide a controlled and enjoyable consumption experience for users seeking the effects of cannabis without the intensity of traditional products. By utilizing all-natural flavors, Cann addresses the demand for healthier, low-calorie alternatives in the beverage market.
Funding: $44.6M
Rough estimate of the amount of funding raised
Funding: $44.6M
Rough estimate of the amount of funding raised
Cellibre utilizes precision fermentation and strain engineering to transform cells into sustainable production systems for high-value products, addressing the environmental impact of traditional manufacturing methods. By optimizing microbial biochemistry, the company enables the large-scale, eco-friendly production of essential ingredients, such as cannabinoids, while minimizing reliance on resource-intensive agricultural practices.
Funding: $30.1M
Rough estimate of the amount of funding raised
Funding: $30.1M
Rough estimate of the amount of funding raised
The startup offers a human resource platform that integrates payroll, benefits administration, and workers' compensation specifically for small to mid-sized businesses. This solution streamlines human capital management processes, significantly reducing administrative time and costs associated with employee-related tasks.
The startup offers an AI-powered visualization tool for home renovations that generates realistic 3D renderings based on user inputs and design preferences. This technology enables homeowners to visualize potential changes and make informed decisions, reducing costly mistakes and enhancing project planning.
This company develops breathalyzer technology to detect recent marijuana use by analyzing biomarkers in breath. Their device offers businesses a tool to monitor employee impairment and promote workplace safety without infringing on legal off-duty consumption.
The startup offers a machine learning-enabled digital platform that provides healthcare professionals with real-time insights into vendor contracts, pricing, and payments. This technology enables hospitals to optimize their procurement of medical devices, resulting in significant time and cost savings.
Funding: $750.0K
Rough estimate of the amount of funding raised
Funding: $750.0K
Rough estimate of the amount of funding raised
Phylos develops phenotypically-stable, fully-feminized F1 hybrid cannabis seeds designed for high-quality production. These seeds offer growers agronomic traits that improve cultivation efficiency while delivering high-THC and unique aromatic profiles. The company provides uniform genetics that rival clonal consistency, mitigating risks like HLVd for modern agricultural operations.
Showing 12 of 23 unmatched portfolio companies